Sodium Glycididazole Reduces the Adverse Reactions of Concurrent Chemoradiotherapy
Clinical trial NCT06667622 · RECRUITING
Trial details
- NCT number
- NCT06667622
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-05-29
- Primary completion
- 2026-01-10
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.